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ABSTRACT 
Matrix-based tablets using 40 %w/w grewia gum were prepared by direct compression to contain 
cimetidine as novel drug. The formulations were compared with similar formulations using 
hydroxypropyl methylcelluose (Methocel®), gum arabic, carboxy methylcellulose (Blanose®), or 
ethyl cellulose (Ethocel®) as polymer matrix. Also binary composite matrices containing grewia 
gum and the reference polymers (40 %w/w total polymer concentration in a ratio of 1:1) were 
directly compressed. In addition to tablet properties, swelling, erosion, kinetics of drug release from 
the matrices and stability of the tablet formulations were also investigated. In vitro drug release 
studies reveal that grewia gum can control the release of cimetidine from tablets for up to 12 hours. 
This strong sustained-release potential of grewia polysaccharide gum was superior to hydrophilic 
matrices of hydroxypropyl methylcellulose, carboxy methylcellulose and gum arabic. The release 
of drug from the grewia polysaccharide gum matrices follows Higuchi kinetic models. There was 
synergy between grewia gum and HPMC in delaying the release of cimetidine from tablets. Grewia 
gum may therefore prove a useful excipient when used alone, or in combination with other 
polymers to modify the release of soluble drugs from polymeric matrices. 
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INTRODUCTION 
A number of approaches have been used to 
obtain controlled drug release, but 
hydrophilic matrix is recognized as the 
simplest and is the most widely used. Upon 
ingestion of a hydrophilic matrix tablet drug 
release results initially from swelling which 
causes a gel layer to form on the tablet 
surface. This gel layer retards further ingress 
of fluid and subsequent drug release.  The 
swelling of the polymer matrix very often 
occur simultaneously with erosion [1], and 
both of them contribute to the overall drug-
release rate. Hydrophillic matrices from 
natural polysaccharide gums such as xanthan 
gum [2, 3, 4, 5], guar gum [6, 7, 8] and karaya 
gum [9] have been shown to provide varying 
degrees of sustained release of medicaments. 
These natural hydrophilic colloids are still 
widely used in pharmaceutical dosage forms 
because of their biocompatibility, low cost 
and free availability [10].   
Grewia polysaccharide gum is obtained by 
extraction from the inner stem bark of the 
plant Grewia mollis (Family, Tiliaceae). The 
plant is found growing abundantly wild or 
cultivated in the middle belt region of Nigeria 
and forms part of the delicacies of the 
inhabitants of the region [11]. Aqueous 
dispersions of the pulverised inner stem bark 
of grewia gum hydrates and swell to form a  
highly viscous dispersion. This property of 
the plant has kindled a lot of interest into the 
potential application of the gum as matrix for 
oral controlled delivery of medicaments. The 
gum has been isolated and some 
physicochemical [12, 13], binding [14], 
rheological [15] and mechanical properties of 
aqueous based grewia gum films [16] have 
been evaluated. 
The formulation of a suitable oral drug 
delivery system for the controlled delivery of 
highly water soluble drugs is a challenging 
task to the formulation scientist [17]. This is 
because most highly water-soluble drugs can 
readily release the drug from the tablet matrix 
faster than desired if not properly formulated. 
In this study single polymer matrix tablets of 
cimetidine were formulated by direct 
compression technique using 40 %w/w 
grewia gum. The tablet properties and release 
from the tablets were compared with 
corresponding tablets made with the 
hydrophilic polymers – hydroxypropyl 
methylcellulose (HPMC), gum arabic, or 
carboxy methylcellulose (CMC), and 
hydrophobic polymer ethyl cellulose. 
Synergism between the reference polymers 
and grewia gum was evaluated by 
formulation of directly compressed binary 
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matrices containing 40% total polymer 
concentration in the ratio 1:1. 
 
MATERIALS AND METHODS 
Materials 
Ethyl cellulose (Ethocel® - standard 100FP 
Premium) and hydroxypropyl methylcellulose 
(Methocel® K100 premium LVCR) was a gift 
from Colorcon, England.  Colloidal silicon 
dioxide (Aerosil®) was a gift from Evonik, 
UK. Carboxy methylcellulose (Blanose® – 
Type 7M1F-PHARM) was a gift from 
Aqualon. Cimetidine was a free gift from 
GlaxoSmithkline, UK. Gum arabic, lactose 
monohydrate, magnesium stearate were 
purchased from Sigma, England. Grewia gum 
(air-dried) was extracted from our laboratory 
as described previously [13].  
 
Preparation and analysis of tablets 
Single polymer and binary composite matrix 
tablets of cimetidine were prepared by direct 
compression. The single polymer matrix 
tablets of cimetidine were made using ethyl 
cellulose, HPMC, carboxy methylcellulose, 
gum arabic (reference polymers), or grewia 
polysaccharide gum (test polymer) as the 
polymer matrix according to the formula 
shown in table 1. Binary composite matrix 
formulations were made using the same 
polymers in a ratio of 1:1 according to the 
formula shown in table 2.  Briefly, all the 
powders were passed through a sieve of 250 
µm before direct compression. The amounts 
of polymer, microcrystalline cellulose and 
cimetidine as shown in the tables were 
accurately weighed, manually blended and 
characterised prior to compression. The 
powders were compressed in a single station 
press, Minipress MII (RIVA, Germany) after 
blending with magnesium stearate and 
colloidal silicon dioxide to give flat faced 
tablets of about 500 mg weight, 13mm 
diameter and an average hardness of 80 N. 
The compressed tablets were stored in air 
tight containers for evaluation.  
 
Characterization of powders 
Moisture content was determined using a 
Sartorius moisture balance (Satorius, 
Germany). Angle of repose was determined 
by the funnel method. Bulk and tapped 
density were determined by the USP tap 
density tester (Sotax TD2, Switzerland) and 
the Hausner ratio was calculated as the ratio 
of tapped to bulk densities. 
Characterization of tablets 
Crushing strength, friability, uniformity of 
weight and content of the tablets were 
evaluated. Tablet crushing strength was tested 
with the model 6D tablet tester (Schulinger 
Pharmatron, Manchester, NH). Friability was 
tested using Roche friability testing 
apparatus. The uniformity of weight test (20 
tablets) was carried out on a class A balance. 
Uniformity of content test (10 tablets) was 
done on all batches of matrix tablets in 
phosphate buffer (pH 7.2) and UV absorbance 
read at 228 nm on a Mattson Galaxy 3020 UV 
spectrophotometer (Unicam, England). 
 
In vitro drug release studies 
Cimetidine release from the matrix tablets 
was studied in 900 mL of phosphate buffer 
(pH 7.2) using the USP II (paddle method) at 
100 rpm and 37 ± 1°C. The dissolution 
equipment was an Erweka, DT 600 (Erweka, 
Germany) equipped with a 40 mesh sinker.  A 
4 mL sample was withdrawn at time intervals 
of 15 minutes, 30 minutes and thereafter 
every 1 hour for 12 hours for both single 
polymer and binary composite matrix 
systems. The withdrawn samples were 
assayed in a UV-spectrophotometer at 228 
nm. After each sampling, and equal volume 
(4 mL) of fresh buffer solution with same 
temperature was replaced.  
 
Water uptake and erosion studies 
Water uptake and erosion studies were also 
carried out in the dissolution apparatus DT 
600 (Erweka, Germany). The matrix tablets, 
in a sinker, were placed in 900 mL of 
phosphate buffer (pH 7.2) equilibrated at 37 ± 
1°C and the paddle rotating at 100 rpm. The 
tablets were allowed to hydrate, swell and 
erode at different time intervals. Two tablets 
were used per time point. At the 
predetermined times (0, 30 minutes, 1, 2, 4 or 
8 hours), the tablets were removed from the 
dissolution vessel and lightly patted with 
tissue paper to remove excess water. The wet 
weight of the tablets was determined and then 
they were dried at 50 °C until a constant 
weight. This remaining dry weight was 
recorded.  
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Table 1: Batch formula for directly compressed single polymer matrix tablets of Cimetidine 
Ingredients Amounts 
Cimetidine (mg) 250 
Polymer (mg) 100 
Microcrystalline cellulose (mg) 125 
Magnesium stearate (mg) 4.75 
Colloidal silicon dioxide  (mg) 14.25 
 
Table 2: Batch formula for directly compressed binary composite matrix tablets of cimetidine 
Ingredients I II III IV V 
Cimetidine (mg) 250 250 250 250 250 
Grewia (mg) 50 50 50 50 50 
Ethyl cellulose (mg) 50 - - - - 
CMC (mg) - - 50 - - 
Methocel® (mg) - - - 50 - 
Gum arabic (mg) - - - - 50 
Microcrystalline cellulose 125 125 125 125 125 
Colloidal silicon dioxide (mg) 14.25 14.25 14.25 14.25 14.25 
Magnesium stearate (mg) 4.75 4.75 4.75 4.75 4.75 
 
Water uptake and erosion were determined 
gravimetrically according to the following 
equations: 
 ܹܽݐ݁ݎ ݑ݌ݐܽ݇݁ ሺ%ሻ ൌ
௪௘௧ ௪௘௜௚௛௧ି௥௘௠௔௜௡௜௡௚ ௗ௥௬ ௪௘௜௚௛௧
௥௘௠௔௜௡௜௡௚ ௗ௥௬ ௪௘௜௚௛௧ ൈ 100                            
    ..equation 1 
 ܧݎ݋ݏ݅݋݊ ሺ%ሻ ൌ
௢௥௜௚௜௡௔௟ ௪௘௜௚௛௧ି௥௘௠௔௜௡௜௡௚ ௗ௥௬ ௪௘௜௚௛௧
௢௥௜௚௜௡௔௟ ௪௘௜௚௛௧ ൈ 100       
    …equation 2 
Kinetic analysis of dissolution data 
The mechanism of drug release from the 
tablet matrices was studied by fitting the 
release data into the zero-order, first-order 
and Higuchi kinetic equations [18]: 
Zero order: Qt = Qo + Kot        …equation 3 
First order: InQt = InQo + K1t  ...equation 4 
Higuchi:          ܳ௧ ൌ ܭுݐଵ/ଶ     …equation 5 
These models fail to explain drug release 
mechanism due to swelling (upon hydration) 
along with gradual erosion of the matrix. 
Therefore, the dissolution data was also fitted 
to the well-known exponential equation 
(Korsmeyer equation), which is often used to 
describe the drug release behaviour from 
polymeric systems [19]: 
Log (Mt/Mf) = Log k + n Log t     equation 6 
Where, Mt is the amount of drug release at 
time t; Mf is the amount of drug release after 
infinite time; k is a release rate constant 
incorporating structural and geometric 
characteristics of the tablet; and n is the 
diffusional exponent indicative of the 
mechanism of drug release. To determine the 
release exponent, the log value of percentage 
drug dissolved was plotted against log time 
for each batch according to the equation. A 
value of n = 0.5 indicates Fickian (case I) 
release; >0.5 but <0.89 for non-Fickian 
(anomalous) release; and >0.89 indicates 
super case II type of release. Case II generally 
refers to the erosion of the polymeric chain, 
and anomalous transport (Non-Fickian) refers 
to a combination of both diffusion and 
erosion controlled drug release [20]. 
The equation of similarity factor (f2) as 
proposed by [21] was employed to compare 
dissolution between the test polymer and the 
reference polymers. 
݈ܵ݅݉݅ܽݎ݅ݐݕ ݂ܽܿݐ݋ݎ, ଶ݂ ൌ 50 ݈݋݃ ൜ቂ1 ൅
ଵ
௡
∑ ሺܴ௧ െ ௧ܶሻଶ௡௡ିଵ ቃ
଴.ହ
ൈ 100ൠ
                            …   equation 7 
Where, n = number of observations made 
Rt = average percentage drug dissolved from 
reference formulation 
Tt = average percentage drug dissolved from test 
formulation 
Stability testing 
Representative formulations were selected for 
stability testing, according to the USP (1999) 
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guidelines. The formulations were kept in 
open amber containers in a stability chamber 
(Firlabo, U.K.) at 25oC and relative humidity 
of 60% and sampled after 0, 15, 30, 45 and 60 
days for evaluation of appearance and drug 
content.  
Statistical Analysis 
The data was subjected to ANOVA using the 
software Instat (GraphPad, San Diego, CA).  
 
RESULTS AND DISCUSSION 
Powder characterisation 
The moisture content and the flow parameters 
of the powder blends are presented in table 3. 
The moisture content of all powders and 
blends was between 6.80 and 8.62%. The 
powder blends for all the formulations 
showed an angle of repose of between 30.0-
32.7o indicating ‘good’ to ‘passable’ flow 
behaviour [22, 23]. The upper limit of this 
angle (i.e. 42o) is considered a good working 
range for most pharmaceutical granules and 
powders [24]. Added glidant improves flow 
when Hausner ratio is between 1.25 and 1.5 
[23] and in order to standardise formulations 
and allow comparisons on a weight for weight 
basis, the amount of colloidal silicon dioxide 
was maintained at 2.9% w/w. 
Tablet properties 
The properties of the directly compressed 
cimetidine tablet formulations are shown in 
table 4. The tablets were of good mechanical 
strength. Tablet friability was low except for 
gum arabic and CMC single polymer matrices 
which may be attributable to lamination of 
some of the tablets in the case of gum arabic 
matrices and chipping in the case of CMC 
matrices. Drug content was between 99 to 
107%.  Weight and content variation between 
tablets of the same batch was minimal and 
within acceptable range as defined in the BP. 
In vitro drug release 
The drug release from the single polymer 
matrices and binary composite matrices of 
cimetidine are shown in fig.1 and 2 
respectively.  The single polymer matrices of 
gum arabic, CMC and HPMC (fig. 1) showed 
a burst effect releasing an amount of drug 
ranging between 20 to 50% within the first 60 
minutes potentially due to initial surface 
erosion [25]. When ethyl cellulose or grewia 
gums are used individually, only 16% of drug 
is released after 120 minutes. The addition of 
grewia gum reduces the initial surface erosion 
of CMC, gum arabic and HPMC and the burst 
effect is eliminated (fig. 2). Consequently all 
the binary composite matrix tablets did not 
show a burst effect, mimicking the release 
profile from the more hydrophobic ethyl 
cellulose matrices [26].  
 
 
Fig 1: Release profiles of cimetidine from the single 
polymer matrices containing 40% w/w of grewia, gum 
arabic, CMC, HPMC or ethyl cellulose in phosphate 
buffer (pH 7.2) solution at 37± 1oC (n=3, mean ± s.d.) 
 
 
Fig 2: Release profiles of cimetidine from the binary 
composite matrices of grewia/gum Arabic (1:1), 
grewia/CMC (1:1), grewia/HPMC (1:1),  or 
grewia/ethyl cellulose (1:1) in phosphate buffer (pH 
7.2) solution at 37± 1oC (n=3, mean ± s.d.) 
 
The time taken for 50% of drug to be released 
from the polymer matrices (t50) and the % 
cimetidine released after 12 hours are shown 
in table 5. The single polymer matrices of 
ethyl cellulose have the longest t50 (663.33 
minutes) followed by grewia gum single 
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polymer matrices with a t50 of 465.0 minutes. 
There was no significant difference between 
the t50  of grewia gum and gum arabic single 
polymer matrices (P>0.05). It can be 
concluded that the  order of sustained release 
of cimetidine from the single polymer matrix 
tablets based on the t50  is: Ethyl cellulose > 
grewia gum = gum arabic > HPMC > CMC. 
The CMC single polymer matrices  gave the 
lowest t50 of 65 minutes indicating the least 
ability to delay the release of cimetidine. 
Only the CMC single polymer matrices 
released 100% of the drug at the end of 12 
hours (fig. 2). 
There was evidence of synergism between 
grewia gum and HPMC when used as binary 
composite matrices for the release of 
cimetidine. The binary matrix tablets of 
grewia gum and HPMC (1:1) had a t50  of 
about 521 minutes which was higher than the 
t50  of either grewia gum or HPMC single 
polymer matrix tablets. 
 
 
 
Table 3: Some properties of powder blends for cimetidine matrix tablets 
 
Table 4: Some properties of cimetidine matrix tablets 
Formulation Weight mg) 
(n=20) 
Thickness(mm) 
(n=10) 
Mechanical 
strength (N) 
Friability 
(%) 
Drug content 
(mg) 
Grewia 531.0±0.01 3.6±0.04 84.2±1.5 0.7±0.3 253.1±0.01 
Gum arabic 565.0±0.01 3.7±0.13 72.2±2.3 7.6±7.5 269.2±0.00 
Ethyl cellulose 544.0±0.01 3.7±0.05 91.0±1.9 0.7±0.3 249.7±0.00 
HPMC 569.5±0.01 3.7±0.04 74.6±2.8 0.8±0.2 247.8±0.00 
CMC 520.5±0.02 3.7±0.04 66.2±3.6 1.9±0.6 250.3±0.00 
Grewia/Gum arabic (1:1) 520.5±0.01 3.4±0.05 84.2±2.9 0.6±0.4 252.5±0.00 
Grewia/Ethyl cellulose (1:1) 517.0±0.02 3.6±0.05 88.6±8.2 0.6±0.6 253.5±0.00 
Grewia/HPMC(1:1) 534.0±0.01 3.4±0.05 81.4±5.9 0.5±0.5 249.2±0.01 
Grewia/CMC (1:1) 518.5±0.01 3.5±0.05 74.6±2.7 0.5±0.5 251.4±0.00 
 
Table 5: Time for 50% cimetidine release (t50) and % cimetidine release from single polymer or binary 
matrices after 12 hours in phosphate buffer (pH 7.2), (n=3, mean±s.d.) 
Formulation t50(min) % release (12h) 
Grewia 465.0±69.5 65.4±3.6 
Gum arabic 356.7±67.5 71.3±2.9 
CMC 65.0±20.0 100.0±0.4 
HPMC 310.0±43.6 76.4±4.1 
Ethyl cellulose 663.3±30.6 53.0±2.4 
Grewia/gum arabic (1:1) 356.7±5.8 73.5±0.7 
Grewia/CMC (1:1) 316.0±2.0 88.7±2.2 
Grewia/HPMC (1:1) 521.7±20.2 65.9±1.5 
Grewia/ethyl cellulose (1:1) 398.3±28.4 71.8±1.1 
Formulation Moisture content 
(%) 
Angle of repose 
(o) 
Hausner ratio 
Grewia 8.5±0.5 30.2±1.3 1.5±0.07 
Gum arabic 8.6±0.6 30.1±1.4 1.2±0.04 
Ethyl cellulose 7.1±0.4 32.7±1.3 1.5±0.01 
HPMC 7.4±0.5 32.2±1.1 1.3±0.01 
CMC 7.7±0.8 30.3±1.7 1.1±0.04 
Grewia/Gum arabic (1:1) 7.6±0.5 30.0±0.7 1.2±0.06 
Grewia/Ethyl cellulose (1:1) 8.0±0.8 31.7±1.2 1.4±0.03 
Grewia/HPMC (1:1) 6.8±1.0 30.3±0.8 1.5±0.04 
Grewia/CMC (1:1) 7.6±0.8 30.5±0.7 1.3±0.03 
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Swelling and erosion 
Swelling and erosion of the single polymer 
matrices and the binary composite matrices 
are shown in fig. 3 and 4 respectively. The 
results show that swelling and erosion occur 
simultaneously for all the matrix tablet 
formulations. The degree of erosion was 
higher for HPMC and CMC single polymer 
matrices. When swelling and erosion of 
matrix tablets occur simultaneously, a 
constant release of drug can be expected from 
the matrices [27]. This is because increase in 
path length which occurs as a result of 
swelling is compensated for by the 
continuous erosion of the matrix that occurs 
simultaneously [28].  
The very low water uptake of ethyl cellulose 
matrices is attributable to the hydrophobic 
nature of the ethyl cellulose matrices. Grewia 
gum has the highest capacity for water uptake 
of all the single polymer matrices studied but 
erosion of the grewia gum single polymer 
matrices was similar to ethyl cellulose. This 
indicates that the capacity of the gum to 
ingress water is much higher than the rate or 
extent of erosion of the matrices. 
Consequently, drug release from grewia gum 
matrices is predominantly by diffusion across 
the swollen matrices. The low erosion of the 
matrices may be attributable to the fact that 
grewia gum does not dissolve upon swelling 
or hydration in aqueous media [13].  
Drug release kinetics 
The kinetics of drug release form the single 
polymer and binary composite matrices were 
plotted according to the various kinetic law 
equations and the regression coefficients and 
the release exponent based on the Korsmeyer-
Peppas model are shown in table 6. 
The grewia gum single polymer matrices 
showed correlation with the Higuchi and 
Korsmeyer-Peppas model (P>0.05). The 
release exponent, n is indicative of non-
Fickian or anomalous transport (table 6). All 
other single polymer matrices also best fitted 
a non-Fickian transport of drug. This 
indicates that drug release from the single 
polymer matrices of grewia gum is diffusion 
controlled with the profile attaining a near 
zero order release. The relative contributions 
of both swelling and erosion to drug release 
for the grewia gum matrices produced a 
release exponent n, of 0.73 indicative of an 
anomalous or non-Fickian drug release 
mechanism except HPMC which showed a 
Fickian release mechanism with best fit to the 
Higuchi release model. The hydrophilic 
polymers such as HPMC, CMC and grewia 
gum swell to form gel layers which gradually 
dissolve or erode. Drug release from such 
hydrophilic matrices is attributable to relative 
contributions of drug diffusion, polymer 
relaxation and matrix erosion [29]. The 
release exponent, n, from CMC matrices was 
1.12, indicative of super case II release. Drug 
transport was primarily by erosion of the 
tablet matrix. This is supported by data from 
swelling and erosion experiments (fig. 3b) 
which showed CMC matrices exhibited the 
highest degree of erosion. 
a.
b.    
 
Fig. 3: Water uptake (a) and erosion (b), of single 
polymer matrices of cimetidine containing  grewia, 
gum arabic, HPMC, CMC or ethyl cellulose in 
phosphate buffer (pH 7.2), (n=2, mean). 
 
For all the binary composite matrices, similar 
mechanism of drug transport predominates. 
The anomalous behaviour seen is attributable 
to relative contributions of drug diffusion, 
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polymer relaxation and matrix erosion [29, 
30, 31]. 
 
a.
  b. 
Fig. 4: Water uptake (a) and erosion (b) with time of  
binary composite matrices of grewia and gum arabic, 
HPMC, CMC or ethyl cellulose  (ratio  1:1) in 
phosphate buffer (pH 7.2),  (n=2, mean). 
 
The similarity factor (f2) was used to compare 
drug release from the polymer matrices (table 
6). The test formulation was the grewia gum 
single polymer matrix formulation. An f2 
value of 100 suggests that the test and 
reference profiles are identical. The 
dissimilarity between release profiles 
increases as the f2 value decreases. The 
highest dissimilarity exists between the 
profiles of grewia gum and CMC single 
polymer matrices (f2 =15.31), while the 
highest similarity is seen between the profiles 
of grewia gum single polymer matrices and 
the binary matrices of grewia/ethyl cellulose 
(1:1) with f2 of 70.95. The dissimilarity 
between grewia gum and CMC single 
polymer matrices may be attributable to the 
relative contribution of swelling or erosion to 
drug transport. While drug transport across 
CMC matrices was predominantly erosion 
controlled, drug transport across grewia gum 
matrices was predominantly by swelling and 
diffusion across the matrix. The order of 
similarity of the reference single polymer 
matrices to grewia gum single polymer matrix 
tablets is ethyl cellulose > gum arabic > 
HPMC > CMC. It can be seen from the 
results that while grewia gum single polymer 
matrices are most similar to ethyl cellulose 
matrices based on the similarity factor f2, the 
gum was most similar to gum arabic based on 
t50. In combination the order is similar with 
the presence of grewia gum exerting the 
major influence. It will appear that similarity 
between grewia gum and the reference 
polymers was greatly determined by the 
degree of erosion of the matrices. 
Consequently, single polymer matrices with 
the lowest degree of erosion of the matrices 
exhibited the highest degree of similarity. 
 
Stability of Cimetidine tablet formulations 
Cimetidine matrix tablet batches did not show 
any change in appearance even after 60 days 
storage at room temperature and 60% relative 
humidity. . There was no significant 
difference (P > 0.05) in the drug content of 
any matrix tablets at the end of the 60 days 
(table 7). Grewia gum matrices for controlled 
release of cimetidine demonstrated good 
product stability over the duration of the 
study, similar to the commercially available 
excipients. The significance of this result to 
grewia polysaccharide gum is that the gum 
may not interfere with the stability of APIs 
when used as an excipient in tablet 
formulation. 
CONCLUSION 
Grewia polysaccharide gum was capable of 
prolonging the release of cimetidine from 
matrix tablets of the gum for up to 12 hours. 
Physicochemical properties such as high 
molecular weight, low solubility, high 
viscosity and long swelling time [13] enable 
grewia polysaccharide gum to function as a 
suitable insoluble polymer matrix for the 
release of active medicaments. This strong 
sustained-release potential of grewia 
polysaccharide gum was superior to 
hydrophilic matrices of HPMC, CMC and  
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Table 6: Kinetic parameters of cimetidine matrix tablets 
 
Table 7: Effect of temperature and relative humidity on drug content (%) stability of cimetidine matrices   
(n=5, mean ± s.d.) 
Formulation Day 0 Day 15 Day 30 Day 45 Day 60 
Grewia 101.1±2.0 99.3±2.1 99.5±1.3 98.8±1.1 98.5±0.6 
Gum arabic 107.9±1.2 106.9±1.3 106.4±1.4 106.3±1.0 106.4±1.2 
Ethyl cellulose 100.1±1.2 99.2±2.0 98.1±2.4 100.1±1.2 99.0±1.1 
HPMC 99.2±1.7 98.2±2.8 98.0±2.9 97.7±2.9 98.8±1.6 
CMC 100.6±1.6 100.4±1.5 99.7±1.3 99.4±1.3 99.1±1.5 
 
gum arabic. The release of drug from the 
grewia polysaccharide gum matrices was 
observed to follow Higuchi kinetic models. 
The gum has a high swelling capacity 
compared with all polymers tested, while 
exhibiting little erosion of the matrix (erosion 
being comparable to ethyl cellulose). 
Synergism was observed between grewia and 
HPMC when combined in the ratio of 1:1 for 
sustained release of cimetidine from tablets in 
which release kinetics tended towards a zero 
order release. The relative abundant 
availability and low cost of grewia gum 
makes it an economically viable alternative 
source of excipient for both the food and 
pharmaceutical industry. When the sustained-
release of an API is indicated, grewia gum 
may therefore not only have economical 
advantages over HPMC and gum arabic, but 
may also extend the duration of release. 
 
ACKNOWLEDGEMENT 
Financial support for this study was provided 
by the British Commonwealth and Aston 
University. 
REFERENCES 
[1] Sujja-areevath, J., Munday, D.L., Cox, P.J., 
Khan, K.A., Relationship between swelling, 
erosion and drug release from hydrophilic 
natural gum mini-matrix formulations. Eur J. 
Pharm Sci. 1998, 6, 207–217. 
 [2] Talukdar, M.M.,Kinget, R., Swelling and drug 
release behaviour of xanthan gum matrix 
tablets. Int. J Pharm. 1995,120 (1), 63-72.  
[3] Billa, N., Yuen, K.H., Formulation variables 
affecting drug release from xanthan gum 
matrices at laboratory scale and pilot scale. 
AAPS PharmSciTech. 2000, 1(4), article 30.  
 [4] El-Gazayerly, O.N., Release of pentoxifylline 
from xanthan gum Matrix Tablets. Drug 
Development and Industrial Pharmacy 2003, 
9(2), 241 – 246. 
[5] Fan, J., Wang, K., Liu, M., He, Z., In vitro 
evaluations of konjac glucomannan and 
xanthan gum mixtures as sustained release 
material of matrix tablet. 
Carbohydrate Polymers 2008, 73(2), 241-
247. 
[6] Toti, U. S., Aminabhavi, T. M., Modified 
guar gum matrix tablet for controlled release 
of diltiazem hydrochloride. Journal of 
Controlled Release 2004,  95 (3), 567-577. 
[7] Krishnaiah, Y. S. R., Karthikeyan, R. S., 
Sankar, V.G., Satyanarayana, V., Three-layer 
gum matrix tablet formulations for oral 
controlled delivery of highly soluble 
trimetazidine dihydrochloride. Journal of 
Controlled Release 2002, 81(1-2), 45-56. 
[8] Krishnaiah, Y. S. R., Karthikeyan, R. S., 
Satyanarayana, V., A three-layer guar gum 
matrix tablet for oral controlled delivery of 
Formulation Release 
exponent 
(n) 
Korsmeye
r-Peppas 
(r2) 
Zero-
order 
kinetic 
(r2) 
First-
order 
kinetic 
(r2) 
Higuchi 
model (r2) 
Similarity 
factor (f2) 
Grewia 0.73±0.04 0.99±0.00 0.96±0.01 0.60±0.02 0.98±0.01 - 
CMC 1.12±0.39 0.89±0.05 0.55±0.06 0.28±0.02 0.76±0.10 15.3±0.3 
Gum arabic 0.59±0.02 0.96±0.00 0.93±0.01 0.53±0.09 0.99±0.00 54.4±11.9 
HPMC 0.47±0.02 0.95±0.02 0.92±0.01 0.41±0.01 0.99±0.002 46.9±5.8 
Ethyl cellulose 0.86±0.01 0.91±0.04 0.91±0.03 0.49±0.05 0.98±0.01 57.0±8.6 
Grewia/CMC (1:1) 0.79±0.02 0.99±0.01 0.97±0.00 0.65±0.01 0.96±0.01 42.7±5.0 
Grewia/gum arabic (1:1) 0.73±0.01 0.98±0.02 0.97±0.00 0.62±0.02 0.97±0.01 61.6±8.2 
Grewia/HPMC (1:1) 0.74±0.01 0.99±0.01 0.99±0.00 0.66±0.02 0.96±0.01 64.8±5.8 
grewia/ethyl cellulose (1:1) 0.77±0.01 0.99±0.01 0.98±0.01 0.63±0.01 0.98±0.00 71.0±10.1 
E.I.Nep et al /J. Pharm. Sci. & Res. Vol.2 (11), 2010,708-716
715
 
 
highly soluble metoprolol tartrate. Int. J. of 
Pharm. 2002, 241(2), 353-366. 
[9] Munday, D.L., Cox, P.J., Compressed 
xanthan and karaya gum matrices: erosion and 
drug release mechanisms. Int. J  Pharm. 2000, 
203 (1-2), 179-192. 
[10] Vendruscolo, C.W., Ferrero, C., Pineda, 
E.A.G., Silveira, J.L.M., Freitas, R.A., 
Jimenez-Castellanos, M.R., Bresolin, T.M.B., 
Physicochemical and mechanical 
characterization of galactomannan from 
Mimosa scabrella: effect of drying method. 
Carbohydrate Polymers 2009, 76, 86-93. 
[11] Keay, F.W.J., Onochie, C.F.A., Standfield, 
D.P., Nigerian trees, Department of Forest 
Research. Ibadan 1964.   
[12] Okafor, I.S., Chukwu, A., Udeala, K., Some 
physicochemical properties of grewia gum. 
Nig  J Polym Sci Technol. 2001, 2 (1), 161-
167. 
[13] Nep, E.I., Conway, B.R., Characterization of 
grewia gum, a potential pharmaceutical 
excipient. Journal of Excipients and Food 
Chemicals 2010, 1(1), 30-40. 
[14] Emeje, M., Isimi, C., Kunle, O., Effect of 
grewia gum on the mechanical properties of 
paracetamol tablet formulations. Afri J 
PharmPharmacol. 2008, 2(1), 001–006. 
[15] Okafor, I.S., The Rheological Properties of 
Grewia Gum. Nig. J. Polym. Sci. Technol. 
2001, 2 (1), 169-176. 
[16] Muazu, J., Musa, H., Musa, K.Y., 
Compression, mechanical and release 
properties of paracetamol tablet containing 
acid treated grewia gum. J. Pharm. Sci. 
Technol.  2009, 1 (2), 74-79. 
[17] Siahi, M.R.,  Barzegar-Jalali, M., 
Monajjemzadeh, F.,  Ghaffari, F. and Azarmi, 
S., Design and evaluation of 1- and 3-layer 
matrices of verapamil hydrochloride for 
sustaining its release. AAPS PharmSciTech  
2005, 6 (4), Article 77. 
[18] Hiuchi, T., Mechanism of sustained-action 
medication: theoretical analysis of rate of 
release of solid drugs dispersed in solid 
matrices. J Pharm Sci. 1963, 52, 1145-1149. 
[19] Korsmeyer, R.W., Gurny, R., Docler, E., 
Buri, P., Peppas, N.A., Mechanism of solute 
release from porous hydrophilic polymers. Int. 
J Pharm. 1983, 15, 25-35. 
[20] Peppas, N.A., Analysis of Fickian and non-
Fickian drug release from polymers. Pharm 
Acta Helv. 1985, 60, 110-111. 
[21] Moore, J. W., Flanner, H. H., Mathematical 
comparison of curves with an emphasis on 
dissolution profiles. Pharm. Technol.  1996, 
20, 64-74. 
[22] Raymus, G. J., Handling of Bulk Solids. In: 
R. H. Perry, & D. Green, (eds.), Chemical 
engineer’s handbook 6th edition, McGraw 
Hill., New York 1985. 
 
[23] Wells, J.I., Aulton, M.E., Pharmaceutical 
preformulation. In: Aulton ME ed. 
Pharmaceutics: the design and manufacture 
of medicines. 3rd ed., Churchill Livingstone, 
Philadelphia 2007, p356. 
[24] Jones, T.M., Pilpel, N., The flow properties of 
granular Magnesia.  J. Pharm, Pharmacol. 
1966, 18, 81- 93.  
[25] Ebube, N.K., Hikal, A., Wyandt, C.M., Beer, 
D.C., Miller, L.G., Jones, A.B., Sustained 
release of acetaminophen from heterogeneous 
matrix tablets, influence of polymer ratio, 
polymer loading and coactive on drug release. 
Pharm Dev Technol. 1997, 2, 161-170. 
[26] Kuksal, A., Tiwary, A.K., Jain, N.K., Jain, S., 
Formulation and in vitro-in vivo evaluation of 
extended- release matrix tablet of zidovudine: 
influence of combination of hydrophilic and 
hydrophobic matrix formers. AAPS 
PharmSciTech 2006, 7 (1), Article 1. 
[27] Efentakis, M., Koutlis, A., Release of 
furosemide from multiple unit and single unit 
preparations containing different viscosity 
grades of sodium alginate. Pharm. Dev. 
Technol. 2001, 6, 91-98. 
[28] Mockel, J.E., Lippold, B.C., Zero-order 
release from hydrocolloid matrices. Pharm. 
Res. 1993, 10, 1066 – 1070. 
[29] Colombo, P., Bettini, R., Santi, P. Peppas, 
N.A., Swellable matrices for controlled drug 
delivery: gel-layer behaviour, mechanisms 
and optimal performance. Research focus, 
2000, 3(6), 197-204. 
[30] Varshosaz, J., Tavakoli, N., Kheirolahi, F., 
Use of hydrophilic natural gums in the 
formulation of sustained-release matrix tablets 
of tramadol hydrochloride, AAPS 
PharmSciTech. 2006, 7(1), article 24. 
[31] Sriamornsak, P., Thirawong, N., Korkerd, K., 
Swelling, erosion and release behaviour of 
alginate-based matrix tablets. European 
Journal of Pharm.& Biopharm. 2007, 66, 
435-450. 
 
 
 
 
 
 
E.I.Nep et al /J. Pharm. Sci. & Res. Vol.2 (11), 2010,708-716
716
